National Cancer Institute; Notice of Meeting, 3216-3217 [2019-01744]
Download as PDF
<![CDATA[
3216
Federal Register / Vol. 84, No. 28 / Monday, February 11, 2019 / Notices
Dated: February 5, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–01756 Filed 2–8–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director, National
Institutes of Health; Notice of Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Advisory Committee on
Research on Women’s Health.
The meeting will be held as a
teleconference call only and is open to
the public to dial-in for participation.
Individuals who plan to dial-in to the
meeting and need special assistance or
other reasonable accommodations in
order to do so, should notify the Contact
Person listed below in advance of the
meeting.
Name of Committee: Advisory Committee
on Research on Women’s Health.
Date: February 25, 2019.
Time: 4:00 p.m. to 5:30 p.m.
Agenda: Concept Clearances for Building
Interdisciplinary Research Careers in
Women’s Health (BIRCWH); Specialized
Centers of Research on Sex Differences
(SCORE); and Administrative Supplements
for Research on Sex/Gender Differences and
Research on the Health or Women of
Understudied, Underrepresented, and
Underreported (U3) Populations.
Place: National Institutes of Health, 6707
Democracy Blvd., Room 400, Bethesda, MD
20817, (Virtual Meeting), Call in number:
650–479–3208, Access Code: 297 335 682,
Meeting Password: ACRWH.
Contact Person: Elizabeth Spencer, R.N.,
Deputy Director, Office of Research on
Women’s Health, Executive Secretary,
ACRWH, National Institutes of Health, 6707
Democracy Blvd., Room 7W444, Bethesda,
MD 20817, 301–402–1770,
elizabeth.spencer@nih.gov.
This notice is being published less than 15
days prior to the meeting due to scheduling
difficulties.
Any member of the public interested in
presenting oral comments to the committee
may notify the Contact Person listed on this
notice at least 10 days in advance of the
meeting. Interested individuals and
representatives of organizations may submit
a letter of intent, a brief description of the
organization represented, and a short
description of the oral presentation. Only one
representative of an organization may be
allowed to present oral comments and if
accepted by the committee, presentations
may be limited to five minutes. Both printed
and electronic copies are requested for the
record. In addition, any interested person
VerDate Sep<11>2014
18:05 Feb 08, 2019
Jkt 247001
may file written comments with the
committee by forwarding their statement to
the Contact Person listed on this notice. The
statement should include the name, address,
telephone number and when applicable, the
business or professional affiliation of the
interested person.
Information is also available on the
Institute’s/Center’s home page: https://
orwh.od.nih.gov/, where an agenda and any
additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
Dated: February 5, 2019.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–01767 Filed 2–8–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: NIGMS Initial Review
Group, Training and Workforce Development
Subcommittee—D, Review the Scientific
Merit of Bridges to the Baccalaureate and
IRACDA Grant Applications.
Date: March 21–22, 2019.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Hotel, One Bethesda
Metro Center, 7400 Wisconsin Avenue,
Bethesda, MD 20814.
Contact Person: Tracy Koretsky, Ph.D.,
Scientific Review Officer, National Institute
PO 00000
Frm 00080
Fmt 4703
Sfmt 4703
of General Medical Sciences, National
Institutes of Health, 45 Center Drive, MSC
6200, Room 3AN.12F, Bethesda, MD 20892,
301 594 2886, tracy.koretsky@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
Special Minority Initiatives; 93.859,
Biomedical Research and Research Training,
National Institutes of Health, HHS)
Dated: February 5, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–01782 Filed 2–8–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Cancer Institute
Clinical Trials and Translational
Research Advisory Committee.
The meeting will be open to the
public. The open session will be
videocast and can be accessed from the
NIH Videocasting and Podcasting
website (https://videocast.nih.gov/).
Name of Committee: National Cancer
Institute Clinical Trials and Translational
Research Advisory Committee.
Date: March 6, 2019.
Time: 11:00 a.m. to 1:00 p.m.
Agenda: Strategic Discussion of NCI’s
Clinical and Translational Research
Programs.
Place: National Institutes of Health,
Building 31, Room 11A01, 31 Center Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Sheila A. Prindiville, MD,
MPH, Director, Coordinating Center for
Clinical Trials, National Institutes of Health,
National Cancer Institute, Coordinating
Center for Clinical Trials, 9609 Medical
Center Drive, Room 6W136, Rockville, MD
20850, 240–276–6173, prindivs@
mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: https://
deainfo.nci.nih.gov/advisory/ctac/ctac.htm,
where an agenda and any additional
E:\FR\FM\11FEN1.SGM
11FEN1
Federal Register / Vol. 84, No. 28 / Monday, February 11, 2019 / Notices
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: February 5, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
Special Minority Initiatives; 93.859,
Biomedical Research and Research Training,
National Institutes of Health, HHS)
DEPARTMENT OF HOMELAND
SECURITY
Dated: February 5, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
U.S. Customs and Border Protection
[FR Doc. 2019–01786 Filed 2–8–19; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
SUMMARY:
Center for Scientific Review; Notice of
Closed Meeting
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel; To review NIH Pathway to
Independence Award (K99/R00)
Applications.
Date: April 4, 2019.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road NW,
Washington, DC 20015.
Contact Person: Rebecca H. Johnson,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
Sciences, National Institutes of Health,
Natcher Building, Room 3AN18C, Bethesda,
MD 20892, 301–594–2771, johnsonrh@
nigms.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
VerDate Sep<11>2014
18:05 Feb 08, 2019
Jkt 247001
Commercial Customs Operations
Advisory Committee
U.S. Customs and Border
Protection (CBP), Department of
Homeland Security (DHS).
ACTION: Committee Management; Notice
of Federal Advisory Committee Meeting.
BILLING CODE 4140–01–P
National Institute of General Medical
Sciences; Notice of Closed Meeting
[Docket No. USCBP–2019–0005]
AGENCY:
BILLING CODE 4140–01–P
[FR Doc. 2019–01744 Filed 2–8–19; 8:45 am]
National Institutes of Health
3217
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Mechanisms
of Cancer Therapeutics 2.
Date: February 25–26, 2019.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road NW,
Washington, DC 20015.
Contact Person: Careen K Tang-Toth,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6214,
MSC 7804, Bethesda, MD 20892, (301)435–
3504, tothct@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: February 5, 2019.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–01768 Filed 2–8–19; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00081
Fmt 4703
Sfmt 4703
The Commercial Customs
Operations Advisory Committee (COAC)
will hold its quarterly meeting on
Wednesday, February 27, 2019, in
Washington, DC. The meeting will be
open to the public.
DATES: The COAC will meet on
Wednesday, February 27, 2019, from
1:00 p.m. to 5:00 p.m. EST. Please note
that the meeting may close early if the
committee has completed its business.
ADDRESSES: The meeting will be held at
the Ronald Reagan Building and
International Trade Center, 1300
Pennsylvania Avenue NW, Horizon
Ballroom, Washington, DC 20004. For
information on facilities or services for
individuals with disabilities or to
request special assistance at the
meeting, contact Ms. Florence ConstantGibson, Office of Trade Relations, U.S.
Customs & Border Protection, at (202)
344–1440 as soon as possible.
Pre-Registration: Meeting participants
may attend either in person or via
webinar after pre-registering using one
of the methods indicated below:
For members of the public who plan
to attend the meeting in person, please
register by 5:00 p.m. EST February 26,
2019, either online at https://
teregistration.cbp.gov/index.asp?w=149
by email to tradeevents@dhs.gov; or by
fax to (202) 325–4290. You must register
prior to the meeting in order to attend
the meeting in person.
For members of the public who plan
to participate via webinar, please
register online at https://
teregistration.cbp.gov/index.asp?w=148
by 5:00 p.m. EST on February 26, 2019.
Please feel free to share this
information with other interested
members of your organization or
association.
Members of the public who are preregistered to attend via webinar and
later need to cancel, please do so by
February 26, 2019, utilizing the
following links: https://
teregistration.cbp.gov/cancel.asp?w=149
to cancel an in person registration; or
https://teregistration.cbp.gov/
E:\FR\FM\11FEN1.SGM
11FEN1
]]>Agencies
[Federal Register Volume 84, Number 28 (Monday, February 11, 2019)]
[Notices]
[Pages 3216-3217]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-01744]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the National Cancer
Institute Clinical Trials and Translational Research Advisory
Committee.
The meeting will be open to the public. The open session will be
videocast and can be accessed from the NIH Videocasting and Podcasting
website (https://videocast.nih.gov/).
Name of Committee: National Cancer Institute Clinical Trials and
Translational Research Advisory Committee.
Date: March 6, 2019.
Time: 11:00 a.m. to 1:00 p.m.
Agenda: Strategic Discussion of NCI's Clinical and Translational
Research Programs.
Place: National Institutes of Health, Building 31, Room 11A01,
31 Center Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Sheila A. Prindiville, MD, MPH, Director,
Coordinating Center for Clinical Trials, National Institutes of
Health, National Cancer Institute, Coordinating Center for Clinical
Trials, 9609 Medical Center Drive, Room 6W136, Rockville, MD 20850,
240-276-6173, prindivs@mail.nih.gov.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
Information is also available on the Institute's/Center's home
page: https://deainfo.nci.nih.gov/advisory/ctac/ctac.htm, where an
agenda and any additional
[[Page 3217]]
information for the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: February 5, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-01744 Filed 2-8-19; 8:45 am]
BILLING CODE 4140-01-P
